ScholarIQanswers from OpenAlex & ORCID
Bradley J. Monk
ResearcherPublications, citations & collaboration network
Bradley J. Monk is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Bradley J. Monk have?
ScholarIQindexed works
Bradley J. Monk has 1,000 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Bradley J. Monk have?
ScholarIQcitation count
Bradley J. Monk has 45,892 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Bradley J. Monk?
ScholarIQh-index
Bradley J. Monk has an h-index of 94 in OpenAlex.
What is the i10-index of Bradley J. Monk?
ScholarIQi10-index
Bradley J. Monk has an i10-index of 427 in OpenAlex.
What is the ORCID of Bradley J. Monk?
ScholarIQorcid
The ORCID for Bradley J. Monk is on the source record.
What is the OpenAlex record for Bradley J. Monk?
ScholarIQopenalex
The OpenAlex for Bradley J. Monk is on the source record.
What are the most-cited papers on Bradley J. Monk?
ScholarIQmost cited works
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt, Amit M. Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A. Ledermann, Domenica Lorusso, Ignace Vergote, Noa Ben-Baruch, Christian Marth, Radosław Mądry, René dePont Christensen, Jonathan S. Berek, Anne Dørum, Anna V. Tinker, Andreas du Bois, Antonio González-Martı́n, Philippe Follana, Benedict B. Benigno, Per Rosenberg, Lucy Gilbert, B.J. Rimel, Joseph Buscema, John Balser, Shefali Agarwal, Ursula A. Matulonis
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
William A. Peters, P.Y. Liu, Rolland J. Barrett, Richard J. Stock, Bradley J. Monk, Jonathan S. Berek, Luís Souhami, Perry W. Grigsby, William Gordon, David S. Alberts
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote, René dePont Christensen, Whitney A. Spannuth Graybill, Mansoor R. Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, К. Jardon, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O’Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley Haggerty, María Jesús Rubio-Pérez, Mark S. Shahin, Giorgia Mangili, William H. Bradley, Ilan Bruchim, Kaiming Sun, Izabela A. Malinowska, Yong Li, Divya Gupta, Bradley J. Monk
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari, Michael W. Sill, Harry J. Long, Richard T. Penson, Helen Huang, Lois M. Ramondetta, Lisa M. Landrum, Ana Oaknin, Thomas Reid, Mario M. Leitão, Helen E. Michael, Bradley J. Monk